CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Frank Watanabe

President and Chief Executive Officer, Arcutis Biotherapeutics, Inc.

Search every verified Frank Watanabe interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Frank Watanabe, President and CEO of Arcutis Biotherapeutics, discussed his leadership philosophy and the company's strategy across several podcast appearances in 2024–2026. He described Arcutis as an inflammation-focused company in medical dermatology, noting three FDA-approved products on the market and a fourth under review. He credited the company's success to a strong drug, a focus on meaningful innovation, and a team that includes practicing dermatology clinicians. Watanabe also discussed the company's pivot to expand into Medicare and Medicaid markets, stating that drug companies have an obligation to make products widely available. Watanabe spoke about his leadership approach, which he said was shaped by his U.S. Navy service and the principle that leaders earn loyalty rather than demand obedience. He described Arcutis's operating principles, including a monthly cash award for employees who exemplify them, and said the company emphasizes comfort with failure as part of taking risks and innovating. He also discussed his views on work-life balance, saying he tracked working 340 days in the prior year but that most days were not full eight-hour days, and that the company offers flexible hours and unlimited paid time off. In a separate discussion, he described the biotech investment environment as difficult, saying "cash is like oxygen," and encouraged industry engagement with BIO, where he serves as vice chairman.

Recent appearances

  • ICT Ep. 2.16 Leading Teams That Take Risks and Deliver Results With Frank Watanabe (3/3)

    April 13, 2026 · 📺 Innovating Clinical Trials

    In Part 3 of 3, Liam and Ted continue their conversation with Frank Watanabe, CEO of Arcutis Biotherapeutics discussing work-life balance, building social capital, and management vs. leadership. The conversation explores leadership at a practical level, from building trust across remote teams to creating flexibility that allows individuals to balance work and life in a way that works for them. Finally, he outlines his vision for Arcutis and what “meaningful innovation” really means focusing on solving real problems that matter to patients and clinicians.

    Watch on YouTube ↗

  • ICT Ep. 2.15 Innovation, Risk and Building Great Teams With Frank Watanabe (2/3)

    April 09, 2026 · 📺 Innovating Clinical Trials

    In Part 2 of 3, Liam and Ted continue their conversation with Frank Watanabe, CEO of Arcutis Biotherapeutics, focusing on what it takes to hire and build high-performing teams in high-risk environments. Frank shares how he approaches hiring beyond technical skills placing strong emphasis on cultural fit, risk tolerance, and the ability to innovate.  The discussion also explores how to create a culture where people feel comfortable taking risks and learning from failure.  From encouraging teams to challenge the status quo to fostering psychological safety through leadership, Frank outlines…

    Watch on YouTube ↗

  • ICT Ep. 2.14 From Navy Officer to CEO: The DNA of Leadership with Frank Watanabe (1/3)

    April 07, 2026 · 📺 Innovating Clinical Trials

    In this episode, Liam and Ted sit down with Frank Watanabe, President and CEO of Arcutis Biotherapeutics, to explore his journey from a Navy officer to a biotech executive and the leadership principles established along the way.  Frank shares how his early experiences in the military and his transition into pharma and biotech influenced his approach to leadership, highlighting a key idea that defines his philosophy: leadership isn’t about authority, it’s about earning trust and loyalty. They discuss how operating principles can become the “DNA” of a company, not just words on a wall, and w…

    Watch on YouTube ↗

  • "Cash Is Oxygen" | Frank Watanabe & Josh Fessel Get Real on Surviving Biotech's Chaos

    February 17, 2026 · 📺 Open Door Salon

    Frank Watanabe is the President and CEO of Arcutis Biotherapeutics, a dermatology biotechnology company based in Los Angeles. He's also the Vice Chairman of BIO. Frank spent 30 years in biopharma after a prior career in national security. Josh Fessel is a physician-scientist who most recently served as Chief Medical Officer and Director of the Office of Translational Medicine at NCATS (National Center for Advancing Translational Sciences) at the NIH. He left federal service after the landscape shifted in ways that conflicted with his values and oaths as a physician. Timestamps: 00:00 Intro…

    Watch on YouTube ↗

  • Frank Watanabe: Self-Improvement

    May 19, 2025 · 📺 ARTO Talent

    In this episode, we sit down with Dr. Frank Watanabe, a titan of biotech and pharma, and leader shaping the future of medicine: CEO of Arcutis Biotherapeutics, one of the few commercial stage Dermatology focused Biopharma companies; leading them from startup to IPO to commercial success. 25+ years in biotech and pharma with expertise across of various Therapeutic areas. Proven leader in life sciences, known for building and scaling companies from early-stage to FDA approval - with leadership forged from time spent in the U.S. Navy. Former roles at Kythera, Lilly Amgen, and Allergan - driving…

    Watch on YouTube ↗

  • Frank Watanabe: The Story of Arcutis

    May 16, 2025 · 📺 ARTO Talent

    In this episode, we sit down with Dr. Frank Watanabe, a titan of biotech and pharma, and leader shaping the future of medicine: CEO of Arcutis Biotherapeutics, one of the few commercial stage Dermatology focused Biopharma companies; leading them from startup to IPO to commercial success. 25+ years in biotech and pharma with expertise across of various Therapeutic areas. Proven leader in life sciences, known for building and scaling companies from early-stage to FDA approval - with leadership forged from time spent in the U.S. Navy. Former roles at Kythera, Lilly Amgen, and Allergan - driving…

    Watch on YouTube ↗

  • 46 - Frank Watanabe, President & CEO at Arcutis Biotherapeutics 💊 🌱

    October 30, 2024 · 📺 Slice of Healthcare Network

    Join us on the latest episode! Our Guest: Frank Watanabe, President & CEO at Arcutis Biotherapeutics. What you'll get out of this episode: -Company Focus: Arcutis Biotherapeutics, under Frank Watanabe, is dedicated to treating inflammatory skin conditions, with three FDA-approved products and a fourth pending. -Significant Milestones: This year, Arcutis launched two new products and partnered with a primary care company to expand its reach. -Patient-Centric Approach: Arcutis prioritizes patient needs by involving dermatology practitioners and patient insights directly in decision-making. -…

    Watch on YouTube ↗

  • The BioHub - The Avetix Podcast - Episode 6 - Frank Watanabe

    February 21, 2024 · 📺 The Biohub

    Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. This week we welcome Frank Watanabe! CEO and President of Arcutis Therapeutics, where he has been since it's founding in 2016. During that time they have done multiple successful raises, an $160M IPO and have developed more than 2 FDA approved products with a 3rd being reviewed. Before this he was COO and co-founder of Kanan Therapeutics and VP of strategy and corporate development at Kythera. He also held numerous exec roles throughout his time at Amgen and Eli Lilly and was involve…

    Watch on YouTube ↗

  • Biotech and Biomedical Experts Gather

    October 07, 2020 · 📺 PeopleMediaWorldwide

    RabbleHealth CEO Aubrey Kelly moderates a panel of biotech and biomedical experts including Frank Watanabe, CEO of Arcutis Biotherapeutics, Steven Binder, CFO of MannKind, Rajit Malhorta, Executive Chairman of Dyve Biosciences Board of Directors, plus a special guest appearance by David Meline, former Amgen CFO now CFO at Moderna Therapeutics. Fascinating conversations with these life science experts!

    Watch on YouTube ↗

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →